Jiayi Gu Selected Research

Cisplatin (Platino)

6/2022	An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity.
1/2022	The disruption and hyperpermeability of blood-labyrinth barrier mediates cisplatin-induced ototoxicity.
3/2020	Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects.
1/2020	Current Strategies to Combat Cisplatin-Induced Ototoxicity.
1/2019	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiayi Gu Research Topics

Disease

8	Neoplasms (Cancer) 05/2023 - 01/2016
5	Ototoxicity 06/2022 - 01/2019
4	Hearing Loss (Hearing Impairment) 06/2022 - 01/2019
3	Choroidal Neovascularization 01/2023 - 10/2020
3	Inflammation (Inflammations) 01/2023 - 10/2020
3	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2016
3	Hypoxia (Hypoxemia) 11/2022 - 10/2020
3	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2016
1	Vascular System Injuries 04/2024
1	Ischemia 04/2024
1	Vascular Diseases (Vascular Disease) 04/2024
1	Pathologic Processes 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 05/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2022
1	Adenocarcinoma of Lung 04/2022
1	Atrophy 01/2022
1	Vascular Tissue Neoplasms 01/2022
1	Stomach Neoplasms (Stomach Cancer) 05/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Enteritis 01/2019
1	Chemical and Drug Induced Liver Injury 01/2014
1	Tuberculosis (Tuberculoses) 01/2014

Drug/Important Bio-Agent (IBA)

5	von Willebrand FactorIBA 01/2023 - 05/2021
5	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 01/2019
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 01/2019
3	AntioxidantsIBA 06/2022 - 03/2020
2	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2016
2	IntegrinsIBA 01/2023 - 05/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2020
1	IonsIBA 04/2024
1	CopperIBA 04/2024
1	ElementsIBA 04/2024
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2023
1	benzamideIBA 05/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	LycopeneIBA 01/2023
1	YY1 Transcription FactorIBA 11/2022
1	human MIRN424 micrornaIBA 11/2022
1	Carrier Proteins (Binding Protein)IBA 11/2022
1	Interleukin-22 (IL-22)IBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2022
1	astaxanthine (astaxanthin)IBA 06/2022
1	GlycogenIBA 04/2022
1	Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA 04/2022
1	Phosphorylases (Glucan Phosphorylase)IBA 04/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	geniposideIBA 01/2021
1	andrographolideIBA 10/2020
1	PlatinumIBA 03/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	HydrogelsIBA 01/2019
1	Polyethylene (Polythene)IBA 01/2019
1	Silk FDA Link 01/2019
1	CarcinogensIBA 01/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2014
1	EnzymesIBA 01/2014
1	BilirubinIBA 01/2014

Therapy/Procedure

4	Therapeutics 05/2023 - 01/2016
2	Lasers (Laser) 01/2023 - 10/2020
1	Urinary Catheters 01/2023
1	Drug Therapy (Chemotherapy) 03/2020
1	Injections 01/2019